Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial-Reference-Cited by-同舟云学术

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Published:2009-07 Issue:9683 Volume:374 Page:56-64
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Priotto Gerardo,Kasparian Serena,Mutombo Wilfried,Ngouama Daniel,Ghorashian Sara,Arnold Ute,Ghabri Salah,Baudin Elisabeth,Buard Vincent,Kazadi-Kyanza Serge,Ilunga Médard,Mutangala Willy,Pohlig Gabriele,Schmid Caecilia,Karunakara Unni,Torreele Els,Kande Victor

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Eliminating human African trypanosomiasis: where do we stand and what comes next?;Simarro;PLoS Med,2008

2. Control and surveillance of African trypanosomiasis: report of a WHO Expert Committee;World Health Organ Tech Rep Ser,1998

3. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment;Burri;Trop Med Int Health,2001

4. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda;Legros;Trans R Soc Trop Med Hyg,1999

5. The situation of sleeping sickness in Angola: a calamity;Stanghellini;Trop Med Int Health,2001

Cited by 441 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To Explore Potential Natural Inhibitors of Cysteine Proteases to Combat Human African Trypanosomiasis and Chagas Disease;Current Medicinal Chemistry;2024-08-27

2. Expanding the applications of a bioluminescent mouse infection model of acute African trypanosomiasis;Frontiers in Chemical Biology;2024-08-13

3. Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies;International Journal for Parasitology: Drugs and Drug Resistance;2024-08

4. Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria;International Journal of Molecular Sciences;2024-04-17

5. Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo;2024-03-30